Has Varun Sundaram, MD received payments from drug or device companies?

Yes. Drug and device makers reported $399,656 in general payments to Varun Sundaram, MD across 653 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Varun Sundaram, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Varun Sundaram, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Varun Sundaram, MD

Urology · Austin, TXNPI 1467895342

Payments from drug & device makers

$399,656in general payments, 2019–2025

Across 653 payments — averaging $612.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Teleflex LLC$254K
Biotissue Holdings Inc.$69K
Palette Life Sciences, Inc.$58K
Coloplast$8K
Intuitive Surgical$3K
Procept Biorobotics Corporation$1K
plus $6K from 44 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Teleflex LLC	216	$253,785
Biotissue Holdings Inc.	145	$69,434
Palette Life Sciences, Inc.	37	$58,083
Coloplast	17	$8,031
Intuitive Surgical	1	$3,000
Procept Biorobotics Corporation	16	$1,223
Boston Scientific	38	$1,179
Bayer	5	$943
Johnson & Johnson(3 entities)	26	$602
Astellas Pharma US Inc	26	$583
AbbVie(2 entities)	19	$371
Pfizer	18	$327
Calyxo, Inc.	2	$229
Olympus America Inc.	6	$169
Urogen Pharma, Inc.	8	$161
Ferring Pharmaceuticals Inc.	9	$144
Sumitomo Pharma America, Inc.	6	$121
Bioprotect Medical, Inc.	1	$115
Merck	5	$112
Endo Pharmaceuticals Inc.	8	$111
AstraZeneca(2 entities)	3	$84
Dendreon Pharmaceuticals LLC	3	$80
Innovation Technologies Inc	1	$68
Janssen Scientific Affairs, LLC	3	$62
Acerus Pharmaceuticals Corporation	3	$55
Smith+Nephew	2	$46
Telix Pharmaceuticals	2	$36
Myriad Genetic Laboratories, Inc.	2	$34
Blue Earth Diagnostics	2	$34
Antares Pharma, Inc.	2	$32
Immunitybio, Inc.	1	$31
Clarus Therapeutics Inc.	2	$26
Alnylam Pharmaceuticals Inc.	1	$24
Cook Medical LLC	1	$24
Sun Pharmaceutical Industries Inc.	1	$23
180 Medical, Inc.	1	$23
Agiliti Surgical, Inc.	1	$23
Travere Therapeutics, Inc.	1	$23
Convatec Inc.	1	$22
Progenics Pharmaceuticals, Inc.	1	$20
Novo Nordisk	1	$20
Therapeuticsmd, Inc.	1	$18
Inspire Medical Systems, Inc.	1	$18
Laborie Medical Technologies Corp.	1	$17
Hollister Incorporated	1	$17
Amgen	1	$16
Tolmar Pharmaceuticals, Inc.	1	$16
Civco Medical Instruments	1	$14
Novartis	1	$14
Profound Medical Corp.	1	$12

How this compares

$399,656 in reported general payments places this provider in the 95th percentile of 878 urology providers in Texas.

See all urology providers in Texas →

Medicare billing

Part B allowed, 2024

$596,230

Medicare patients

590

Services billed

8,974

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Austin

Michael TrotterAustin$892K
Elizabeth MobleyAustin$283K
Parviz KavoussiAustin$251K
Peter RuffAustin$168K
Zvi SchiffmanHouston$17.8M
Jose de la CerdaSan Antonio$9M
Daniel SaltzsteinSan Antonio$5.8M
Jose KaramHouston$5.7M
Daniel ZainfeldSan Antonio$4.7M
Brian MazzarellaLakeway$4.5M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →